Who Paid My Doc
John Marraccini
Forensic Pathology South Miami, FL Medical Doctor
NPI 1679651665 CMS profile 303177
6280 Sunset Dr, Suite 407, South Miami, FL 33143
General payments
$1,182
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Marraccini of South Miami, FL is reported in the CMS Open Payments database as having received $1,182 across 59 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $200 | 10 | |
| 2024 | General | $270 | 14 | |
| 2023 | General | $150 | 7 | |
| 2022 | General | $42 | 2 | |
| 2021 | General | $176 | 9 | |
| 2020 | General | $161 | 9 | |
| 2019 | General | $183 | 8 |
Beside peers
- John Marraccini
- Forensic Pathology median
- Middle half of Forensic Pathology
- National median
In program year 2025, general payments to John Marraccini were reported at $200. Among 23 Forensic Pathology profiles paid that year, the median was $92 and the middle half received between $34 and $166.
Show as a table
| Year | John Marraccini | Forensic Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $183 | $61 | $32–$127 | $163 |
| 2020 | $161 | — | — | $114 |
| 2021 | $176 | — | — | $132 |
| 2022 | $42 | — | — | $149 |
| 2023 | $150 | $71 | $22–$133 | $160 |
| 2024 | $270 | — | — | $164 |
| 2025 | $200 | $92 | $34–$166 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 40 drugsPart D claims
1,173
Drug cost
$17,438
Branded share of claims
7.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Paxlovid Nirmatrelvir/Ritonavir | Brand | 20 | $2,859 | |
| Synthroid Levothyroxine Sodium | Brand | 12 | $1,577 | |
| Rosuvastatin Calcium | Generic | 124 | $1,433 | |
| Atorvastatin Calcium | Generic | 117 | $1,366 | |
| Levothyroxine Sodium | Generic | 68 | $850 | |
| Ezetimibe | Generic | 13 | $629 | |
| Lisinopril | Generic | 43 | $557 | |
| Pravastatin Sodium | Generic | 37 | $554 | |
| Eszopiclone | Generic | 30 | $521 | |
| Amlodipine Besylate | Generic | 56 | $518 |
The 10 drugs with the highest cost, of 40 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 205 Part D prescribers listed as Pathology; they describe a distribution and say nothing about conduct.
Payments and prescribing
First 5 of 7 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| MOUNJARO |
|
$52 | — | — |
| Veozah |
|
$41 | — | — |
| SHINGRIX |
|
$32 | — | — |
| AREXVY |
|
$32 | — | — |
| ZEPBOUND |
|
$22 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 7 in the dashboard with a free accountRecords
59 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Forensic Pathology in Florida
Michael Bell
Forensic Pathology · West Palm Beach, FL
Kenneth Hutchins
Forensic Pathology · Miami, FL
Wendy Stroh
Forensic Pathology · Gainesville, FL
Jesse Giles
Forensic Pathology · Jacksonville, FL
Barbara Person
Forensic Pathology · Leesburg, FL
Anthony Clark
Forensic Pathology · Tallahassee, FL
Related records
Forensic Pathology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Forensic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.